Coronavirus Update: Our team is here to help our clients and readers navigate these difficult times. Visit our Resources page now »

Skip to Main Content
DeciBio Consulting logo

DeciBio Consulting


2020 Vault Rankings

At a Glance


“The industry niche and deep expertise.”

“The firm culture is one of a kind.”

“Rapid growth of responsibilities.”


“Lesser known brand name.”

“Lack of formal training.”

“Growing pains of a small firm.”

About DeciBio Consulting

DeciBio Consulting is a boutique strategy consulting and market research firm focusing on the life science industry.  DeciBio's mission is to provide the market intelligence and strategic insights that drive disruption and innovation in the research tools, clinical diagnostics, and medical device markets.

Headquartered in Santa Monica, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 healthcare corporations. DeciBio addresses business solutions in the areas of market landscape analysis, product development, voice-of-customer feedback, new product launches, technology assessment, competitive landscape analysis, business case strategy, and commercial due diligence.

In the News

July 2019

DeciBio Consulting acquires diagnostic database products from The Emmes Group

Los Angeles, CA – DeciBio announced the acquisition of the Emmes Group’s diagnostic database products.  Founded by current President and CEO Ed Weiner, the Emmes Group has been a leading provider of market intelligence data to the diagnostics industry for over 20 years, counting all major diagnostics manufacturers among its customers.  The Emmes Group’s diagnostic database products will provide DeciBio with valuable real-world market intelligence to support DeciBio’s mission to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine industry.  According to DeciBio partner David Cavanaugh, “DeciBio Consulting has leveraged data from the Emmes Group and has enjoyed a great business relationship with Ed Weiner for many years.  We are thrilled to be partnering with the Emmes Group to continue to develop and enhance the diagnostic database products for years to come.”

April 2019  

DeciBio welcomes Andrew Aijian as its first new Partner

In promoting Andrew Aijian, Ph.D., to Partner, DeciBio Consulting announces its first addition to the Partnership since its formation.

At DeciBio, Andrew advises clients on the activities, strategies, and opportunities accompanying the emergence of cancer immunotherapies and has actively expanded DeciBio’s pharma and biotech practice.  Andrew has led projects across a wide variety of segments within the research tools and clinical diagnostics landscapes, including, among others, infectious disease diagnostics, health IT, translational pathology, genomics instruments and reagents, proteomics research tools, and oncology diagnostics and biomarkers.  He has also contributed to multiple market research reports, developed DeciBio’s clinical trial biomarker analysis platform (BioMAP), and advised on the spin-out of DeciBio Analytics -- DeciBio’s data analysis and market intelligence tools unit.

Andrew first joined DeciBio in 2013, as a Ph.D. intern and became a full-time employee in 2014.  

January 2019

DeciBio spins off technology products as a subsidiary entity, DeciBio Analytics

Los Angeles, CA – DeciBio Consulting announces the formation of DeciBio Analytics, a dedicated unit for the development of market intelligence informatics tools and technologies and informatics-oriented consulting engagements.  With the mission to accelerate innovation in the precision medicine space by building novel and propriety solutions that empower stakeholders, DeciBio Analytics will develop both open platforms and proprietary tools for clients to better harness and analyze the wealth of information continuously generated about the precision medicine industry.  A wholly-owned subsidiary of DeciBio Consulting, DeciBio Analytics is led by Pranay Madan, who is responsible for developing and executing  the product strategy.

August 2019

DeciBio expands parental support and professional development benefits

This summer, DeciBio introduced new benefits that offer custom-tailored enrichment opportunities and support for employees. Highlights include:

  • The DeciBio “Intrapreneurship” Program provides eligible employees with customized professional development opportunities via “pet projects” and inter-company experiences throughout the world. 
  • DeciBio’s Parental Support policies support all parents (regardless of gender) as they welcome the birth, adoption, or foster care placement of a child. Eligible employees will receive their full salary during the first twelve weeks of any new parent leave taken within one year of the new child’s arrival. Further, employees will receive their full salary during the first four weeks of any pregnancy disability leave taken during their pregnancy. And, based on each new parent’s unique needs, DeciBio will work with the employee to create a supportive work environment via, e.g., flexibility, part-time employment opportunities, work-from-home opportunities, and wellness room accessibility. 
DeciBio Consulting

10250 Constellation Blvd
Los Angeles, CA 90067
Phone: (310) 451-4510

Firm Stats

Employer Type: Private
Partner: Stephane Budel
Partner: David Cavanaugh
Partner: Andrew Aijian
2019 Employees (All Locations): 50

Major Office Locations

Los Angeles, CA
Oakland, CA

Major Departments & Practices

Precision Medicine

Clinical Diagnostics

Life Science Research Tools

Digital Health and Patient Health Technologies

Commercial Due Diligence